Delivery Order SPE2DB20D2104-SPE2DB24FT03R
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a ceiling value of $2,342.27 and a period of performance through February 27, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $12,759.44 and a completion date of May 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $6,286.55, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has a firm fixed price and a completion date of September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $23,604.03 and a final completion date of June 25, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $15,954.35 and a performance period through June 25, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,179.39, is for the delivery of the prescription medication Contrave ER 8-90 mg tablet in quantities of 120 per order. The contract is a firm fixed-price, non-set-aside agreement with a completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.76, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $17,875.29 and a completion date of July 9, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565455816 - CONTRAVE ER 8-90 MG TABLET 120S. The firm-fixed-price contract has a ceiling value of $7,785.50 and an ultimate completion date of August 15, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,906.12, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of July 16, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT03RDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication, with a total ceiling value of $5,191.24. The contract is a firm fixed-price delivery order with a completion date of March 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is a task order under that larger IDC framework. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 3/13/24 |